1. | EXECUTIVE SUMMARY |
1.1. | Executive introduction: Electronic skin patches |
1.2. | Application overview |
1.3. | Applications, market sizes and outlook |
1.4. | CGM leads the way |
1.5. | Insulin pumps and patch pumps |
1.6. | Diabetes management: full historic data and forecast |
1.7. | Monitoring the heart via skin patches |
1.8. | Players and product types in cardiac monitoring |
1.9. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
1.10. | Cardiac monitoring skin patches: Market forecasts |
1.11. | Skin patches patient monitoring: Historic data: 2010-2019 |
1.12. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
1.13. | Skin patch temperature sensing: Use cases across 12 case studies |
1.14. | Key conclusions: Temperature sensing skin patches |
1.15. | Electrical stimulation product types |
1.16. | Skin patches in bioelectronic medicine |
1.17. | Electrical stimulation via skin patches: Market data (2010-2019) |
1.18. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
1.19. | Introduction - Iontophoresis |
1.20. | Iontophoresis via skin patches: Market data (2010-2019) |
1.21. | Iontophoresis via skin patches: Market forecast (2020-2030) |
1.22. | Key conclusions: Iontophoresis |
1.23. | Examples of players from case studies |
2. | INTRODUCTION |
2.1.1. | The case for skin patches: Augmenting the human body |
2.1.2. | The case for skin patches: Improving device form factor |
2.1.3. | Definitions and exclusions |
2.1.4. | History of skin patches |
2.1.5. | Applications, market sizes and outlook |
2.1.6. | Reimbursement drives commercial business models |
2.1.7. | Patents: Total active patents by assignee |
2.1.8. | Patents over time |
2.1.9. | Patents: Active and strong patents by assignee |
2.1.10. | Context: Wearables hype |
2.1.11. | Glossary |
2.2. | Application overview |
2.2.1. | Skin patches competing with established products |
2.2.2. | New market creation around skin patches |
2.2.3. | Section contents |
3. | DIABETES MANAGEMENT VIA SKIN PATCHES |
3.1.1. | Background: Diabetes in numbers |
3.1.2. | Background: Diabetes on the rise |
3.1.3. | Background: The cost of diabetes |
3.1.4. | Diabetes management process |
3.1.5. | Diabetes management device roadmap: Summary |
3.1.6. | Diabetes management device roadmap: Sensors |
3.1.7. | The case for continuous glucose monitoring (CGM) |
3.1.8. | Anatomy of a typical CGM device |
3.1.9. | Anatomy of a CGM sensor |
3.1.10. | CGM is deployed via skin patches |
3.1.11. | Non-invasive glucose monitoring? |
3.1.12. | Opinions against non-invasive glucose monitoring |
3.2. | Key players in continuous glucose monitoring (CGM) |
3.2.1. | CGM: Overview of key players |
3.2.2. | Abbott Laboratories |
3.2.3. | Abbott: FreeStyle Libre |
3.2.4. | Abbott: SMBG vs CGM comparison |
3.2.5. | Dexcom |
3.2.6. | Medtronic |
3.2.7. | Medtronic: Patents in CGM |
3.2.8. | Roche |
3.2.9. | Roche: Patents in CGM |
3.2.10. | Senseonics |
3.3. | Other players |
3.3.1. | Ascensia & POCTech |
3.3.2. | AgaMatrix & WaveForm Technologies |
3.3.3. | PKVitality |
3.3.4. | Sano |
3.3.5. | DiabeLoop |
3.3.6. | Verily / Google: Contact lenses |
3.4. | Insulin delivery |
3.4.1. | Diabetes management device roadmap: Insulin delivery |
3.4.2. | Insulin pumps: Introduction |
3.4.3. | Insulin pumps currently available |
3.4.4. | Insulin pump breakdown |
3.4.5. | Insulin patch pumps |
3.4.6. | Example: Progress from Medtronic |
3.4.7. | Outlook for insulin pumps |
3.5. | Linking insulin pumps and CGM: Towards an artificial pancreas |
3.5.1. | Today: Hybrid closed loop systems |
3.5.2. | Example: Progress from Medtronic |
3.5.3. | The objective: Closing the feedback loop |
3.5.4. | Examples and partnerships |
3.6. | Market data: Historic & forecasts |
3.6.1. | A shifting focus in diabetes management - Historic data: 2010-2019 |
3.6.2. | Test strip business in decline |
3.6.3. | The growth of CGM accelerates |
3.6.4. | Diabetes management: full historic data and forecast |
3.6.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
4. | CARDIOVASCULAR MONITORING SKIN PATCHES |
4.1.1. | Introduction - Cardiovascular monitoring via wearable devices |
4.1.2. | Introduction - Measuring biopotential |
4.1.3. | Technology overview - the circuitry for measuring biopotential |
4.1.4. | Introduction - Electrocardiography (ECG, or EKG) |
4.1.5. | Devices for cardiac monitoring |
4.1.6. | Cardiac monitoring device types - skin patches |
4.1.7. | Companies and product types |
4.1.8. | Technology overview - electrode properties |
4.1.9. | Disposable Ag/AgCl electrodes |
4.1.10. | Electrodes: Traditional approaches |
4.1.11. | Skin patches with disposable electrodes |
4.1.12. | Skin patches with integrated electrodes |
4.1.13. | Reimbursement codes for wearable cardiac monitors |
4.1.14. | 2021: New reimbursement structure in place |
4.2. | Players |
4.2.1. | Summaries and interviews with 20 industry players |
4.2.2. | BioTelemetry, Inc. |
4.2.3. | BioTelemetry: Timeline |
4.2.4. | iRhythm |
4.2.5. | ScottCare |
4.2.6. | VivaLNK |
4.2.7. | Fukuda Denshi |
4.2.8. | Fujita Medical Instruments |
4.2.9. | Bittium |
4.2.10. | Byteflies & Quad Industries |
4.2.11. | Cardiomo |
4.2.12. | Vivomi |
4.2.13. | QT Medical |
4.2.14. | SWMedical |
4.2.15. | SWMedical - CardiNova |
4.2.16. | Seers Technology |
4.2.17. | Rooti |
4.2.18. | Preventice Solutions |
4.2.19. | Sigknow |
4.2.20. | Borsam |
4.2.21. | Cortrium |
4.2.22. | Qardio |
4.2.23. | Holst Center: Skin patches |
4.2.24. | Medtronic: SEEQ MCT (discontinued) |
4.2.25. | LumiraDx / FitLinxx: Ampstrip (discontinued) |
4.3. | Competition with other form factors |
4.3.1. | Other form factors for ambulatory cardiac monitoring |
4.3.2. | Wearable vs implantable monitoring |
4.3.3. | Example: Medtronic (SEEQ & LINQ) |
4.3.4. | Comparison: Chest straps |
4.3.5. | Comparison: Apparel |
4.3.6. | Comparison: Portable devices |
4.3.7. | Comparison: Smartwatch optical HRM |
4.4. | Market data and forecasts |
4.4.1. | Market overview and forecasts |
4.4.2. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
4.4.3. | Cardiac monitoring skin patches: Market forecasts |
4.4.4. | Comparison - 2019 & 2020 report forecasts |
4.4.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
4.4.6. | Key conclusions: cardiac monitoring skin patches |
5. | GENERAL PATIENT MONITORING |
5.1.1. | Introduction |
5.2. | Wireless inpatient monitoring via skin patches |
5.2.1. | Inpatient monitoring: The case for removing the wires |
5.2.2. | Players and approaches |
5.2.3. | Sensium (Surgical Company Group) |
5.2.4. | VitalConect |
5.2.5. | Isansys Lifecare |
5.2.6. | Leaf Healthcare |
5.3. | Pregnancy monitoring with skin patches |
5.3.1. | GE Healthcare - Monica Novii |
5.4. | General outpatient monitoring with skin patches |
5.4.1. | Qualcomm Life |
5.4.2. | Qualcomm Life / Capsule Technologies |
5.4.3. | LifeSignals |
5.4.4. | Samsung |
5.4.5. | MC10 |
5.4.6. | DevInnova / Scaleo Medical |
5.4.7. | Avanix |
5.4.8. | Avanix - business model and target milestones |
5.5. | Market forecasts |
5.5.1. | Skin patches patient monitoring: Historic data: 2010-2019 |
5.5.2. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
5.5.3. | Conclusions & related areas |
6. | TEMPERATURE SENSING SKIN PATCHES |
6.1. | Introduction - Body Temperature |
6.2. | Temperature sensing technology options |
6.3. | Approaches and standards for medical temperature sensing |
6.4. | Skin patches for temperature sensing |
6.5. | Skin patch temperature sensing: Use cases across 12 case studies |
6.6. | VivaLNK |
6.7. | VivaLNK & Reckitt Benckiser |
6.8. | Blue Spark |
6.9. | Blue Spark & TempTraq® |
6.10. | Life Science Technology |
6.11. | Isansys Lifecare |
6.12. | Raiing Medical |
6.13. | Bonbouton |
6.14. | CSEM |
6.15. | Covestro |
6.16. | Chois Technology |
6.17. | Alternative options: Tympanic temperature sensing |
6.18. | Key conclusions: Temperature sensing skin patches |
7. | ELECTRICAL STIMULATION WITH SKIN PATCHES |
7.1.1. | Introduction: Types of electrical stimulation |
7.1.2. | Differentiation for electrical stimulation |
7.1.3. | Nomenclature in electrical stimulation |
7.1.4. | Electrical stimulation product types |
7.1.5. | Medical vs non-medical devices |
7.1.6. | Bioelectronic Medicine: Definition and background |
7.1.7. | Major Forms of Bioelectronic Medicine |
7.1.8. | The Evolution of Bioelectronic Medicine |
7.1.9. | Skin patches in bioelectronic medicine |
7.2. | TENS |
7.2.1. | TENS - Introduction |
7.2.2. | Innovative Health Solutions: NSS-2 Bridge |
7.2.3. | BeWellConnect: MyTens |
7.2.4. | NeuroMetrix: Quell |
7.2.5. | Theranica: Nerivio Migra |
7.3. | EMS / NMES / FES |
7.3.1. | EMS, NMES and FES |
7.3.2. | Applications of EMS / NMES |
7.3.3. | Example: Russian Stimulation |
7.3.4. | Example: Therapeutic settings and uses |
7.3.5. | Properties of the stimulation (as presented with a therapeutic focus) |
7.3.6. | First Kind Medical: geko |
7.3.7. | Example: HiDow |
7.3.8. | Hivox Biotek |
7.4. | Market data and forecasts |
7.4.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
7.4.2. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
8. | IONTOPHORESIS SKIN PATCHES: COSMETICS AND DRUG DELIVERY |
8.1.1. | Introduction - Iontophoresis |
8.2. | Cosmetics |
8.2.1. | Cosmetic skin patches |
8.2.2. | Estée Lauder |
8.2.3. | BioBliss™, Iontera, Patchology |
8.2.4. | Feeligreen (Feeligold) |
8.3. | Drug delivery |
8.3.1. | Iontophoresis for drug delivery |
8.3.2. | Drugs studied for iontophoretic delivery |
8.3.3. | Commercial activity with drug delivery patches |
8.3.4. | Feeligreen (Feelicare) |
8.3.5. | Seoul National University: Parkinson's medication via skin patches |
8.4. | Reverse iontophoresis |
8.4.1. | Example: GlucoWatch |
8.4.2. | Nemaura Medical: sugarBEAT |
8.5. | Market forecasts and conclusions |
8.5.1. | Iontophoresis via skin patches: Market data (2010-2019) |
8.5.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
8.5.3. | Key conclusions: Iontophoresis |
9. | SWEAT SENSING: SWEAT RATE AND BIOMARKERS |
9.1.1. | Introduction - Sweat sensing |
9.1.2. | Measuring sweat rate |
9.1.3. | Technology overview - measuring bioimpedance |
9.1.4. | Technology overview - Galvanic skin response (GSR) |
9.1.5. | Technology overview - humidity sensors for sweat |
9.1.6. | GE Global Research |
9.2. | Sensing biomarkers in sweat |
9.2.1. | Technology overview - chemical sensing in sweat |
9.2.2. | Sweat vs other sources of analytes |
9.2.3. | Analytes in sweat |
9.2.4. | Technology overview: Chemical sensing |
9.2.5. | Biolinq |
9.2.6. | Kenzen |
9.2.7. | Milo Sensors |
9.2.8. | Eccrine Systems |
9.2.9. | PARC / UCSD |
9.2.10. | Stanford and UC Berkeley |
9.2.11. | Xsensio |
9.2.12. | Epicore Biosystems |
9.2.13. | Key conclusions: Sweat sensing |
10. | WOUND MONITORING AND TREATMENT WITH SKIN PATCHES |
10.1. | Wound Monitoring |
10.2. | Wound Monitoring: KAUST |
10.3. | Wound Monitoring: Purdue University |
10.4. | Wound Monitoring: Tufts University |
10.5. | Wound Monitoring: Tyndall National Institute |
10.6. | Wound Monitoring: UC Berkeley |
10.7. | Wound Monitoring: UCSD |
10.8. | Wound Monitoring: VTT |
10.9. | Wound Treatment |
11. | MOTION SENSING WITH SKIN PATCHES |
11.1.1. | Introduction - Monitoring motion via skin patches |
11.1.2. | Different modes for sensing motion |
11.2. | Measuring motion with inertial measurement units |
11.2.1. | Introduction - Inertial measurement units |
11.2.2. | Measuring motion with IMUs: Examples |
11.2.3. | Value chain and examples of players |
11.2.4. | IMUs in skin patches |
11.2.5. | Measuring motion with conformal sensors |
11.2.6. | Introduction - alternatives for measuring motion |
11.2.7. | Technology overview - Resistive/piezoresistive sensing |
11.2.8. | Players and industry dynamic |
11.2.9. | Peratech |
11.2.10. | Quantum tunnelling composite: QTC® |
11.2.11. | QTC® vs. FSR™ vs. piezoresistor? |
11.2.12. | Bebop Sensors |
11.2.13. | Bainisha |
11.2.14. | Technology overview - Capacitive sensing |
11.2.15. | Parker Hannifin |
11.2.16. | Stretchsense |
11.2.17. | LEAP Technology |
11.2.18. | Technology overview - Piezoelectric sensing |
11.3. | Application examples |
11.3.1. | Applications for skin patch motion sensors |
11.3.2. | Case study - Concussion detection |
11.3.3. | X2 Biosystems |
11.3.4. | US Military head trauma patch / PARC |
11.3.5. | Key conclusions: Motion sensing |
12. | SKIN PATCHES AS A COMMUNICATION GATEWAY TO IMPLANTS |
12.1.1. | Communication with implants |
12.2. | Examples in bioelectronic medicine |
12.2.1. | Skin patches with bioelectronic medicine implants |
12.2.2. | NeuroRecovery Technologies |
12.2.3. | Stimwave: Freedom SCS |
12.2.4. | SPR Therapeutics: Sprint PNS |
12.2.5. | Bioness: StimRouter |
12.3. | Other examples |
12.3.1. | Proteus Digital Health |
12.3.2. | GraftWorx |
13. | OTHER APPLICATIONS OF SKIN PATCHES |
13.1. | Bladder volume sensing (wearable ultrasound) |
13.1.1. | Novioscan |
13.1.2. | Triple W - D Free |
13.2. | Other healthcare & medical applications |
13.2.1. | Acoustic respiration rate (Acurable, Masimo, etc.) |
13.2.2. | UV protection |
13.2.3. | MC10 & L'Oréal: Wisp |
13.2.4. | Lief Therapeutics: Stress Management |
13.3. | Others |
13.3.1. | EOG - eye tracking with skin patches |
14. | MARKET FORECASTS |
14.1.1. | Forecast details and assumptions |
14.2. | Diabetes management forecasts |
14.2.1. | A shifting focus in diabetes management - Historic data: 2010-2019 |
14.2.2. | Test strip business in decline |
14.2.3. | The growth of CGM accelerates |
14.2.4. | Diabetes management: full historic data and forecast |
14.2.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
14.3. | Cardiovascular monitoring forecasts |
14.3.1. | Market overview and forecasts |
14.3.2. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
14.3.3. | Cardiac monitoring skin patches: Market forecasts: 2020-2030 |
14.3.4. | Comparison - 2019 & 2020 report forecasts |
14.3.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
14.4. | Patient monitoring forecasts |
14.4.1. | Skin patches patient monitoring: Historic data: 2010-2019 |
14.4.2. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
14.5. | Electrical stimulation forecasts |
14.5.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
14.5.2. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
14.6. | Temperature sensing forecasts |
14.6.1. | Key conclusions: Temperature sensing skin patches |
14.7. | Iontophoresis forecasts |
14.7.1. | Iontophoresis via skin patches: Market data (2010-2019) |
14.7.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
14.8. | Other skin patch forecasts |
14.8.1. | Other skin patches |
15. | LIST OF 121 ELECTRONIC SKIN PATCH PRODUCTS AND PLAYERS |
15.1. | List of company profiles and interviews |